17047299|t|The TGF-beta1/upstream stimulatory factor-regulated PAI-1 gene: potential involvement and a therapeutic target in Alzheimer's disease.
17047299|a|Amyloid peptide (A beta) aggregates, derived from initial beta-site proteolytic processing of the amyloid precursor protein (APP), accumulate in the brains of Alzheimer's disease patients. The plasmin-generating cascade appears to serve a protective role in the central nervous system since plasmin-mediated proteolysis of APP utilizes the alpha site, eventually generating nontoxic peptides, and plasmin also degrades A beta. The conversion of plasminogen to plasmin by tissue-type plasminogen activator in the brain is negatively regulated by plasminogen activator inhibitor type-1 (PAI-1) resulting in attenuation of plasmin-dependent substrate degradation with resultant accumulation of A beta. PAI-1 and its major physiological inducer TGF-beta1, moreover, are increased in models of Alzheimer's disease and have been implicated in the etiology and progression of human neurodegenerative disorders. This review highlights the potential role of PAI-1 and TGF-beta1 in this process. Current molecular events associated with TGF-beta1-induced PAI-1 transcription are presented with particular relevance to potential targeting of PAI-1 gene expression as a molecular approach to the therapy of neurodegenerative diseases associated with increased PAI-1 expression such as Alzheimer's disease.
17047299	4	13	TGF-beta1	Gene	7040
17047299	52	57	PAI-1	Gene	5054
17047299	114	133	Alzheimer's disease	Disease	MESH:D000544
17047299	152	158	A beta	Gene	351
17047299	233	258	amyloid precursor protein	Gene	351
17047299	294	313	Alzheimer's disease	Disease	MESH:D000544
17047299	314	322	patients	Species	9606
17047299	328	335	plasmin	Gene	5340
17047299	426	433	plasmin	Gene	5340
17047299	532	539	plasmin	Gene	5340
17047299	554	560	A beta	Gene	351
17047299	580	591	plasminogen	Gene	5340
17047299	595	602	plasmin	Gene	5340
17047299	606	639	tissue-type plasminogen activator	Gene	5327
17047299	680	718	plasminogen activator inhibitor type-1	Gene	5054
17047299	720	725	PAI-1	Gene	5054
17047299	755	762	plasmin	Gene	5340
17047299	826	832	A beta	Gene	351
17047299	834	839	PAI-1	Gene	5054
17047299	876	885	TGF-beta1	Gene	7040
17047299	924	943	Alzheimer's disease	Disease	MESH:D000544
17047299	1004	1009	human	Species	9606
17047299	1010	1037	neurodegenerative disorders	Disease	MESH:D019636
17047299	1084	1089	PAI-1	Gene	5054
17047299	1094	1103	TGF-beta1	Gene	7040
17047299	1162	1171	TGF-beta1	Gene	7040
17047299	1180	1185	PAI-1	Gene	5054
17047299	1266	1271	PAI-1	Gene	5054
17047299	1330	1356	neurodegenerative diseases	Disease	MESH:D019636
17047299	1383	1388	PAI-1	Gene	5054
17047299	1408	1427	Alzheimer's disease	Disease	MESH:D000544
17047299	Positive_Correlation	5054	7040
17047299	Association	MESH:D000544	351
17047299	Association	351	5054
17047299	Negative_Correlation	351	5340
17047299	Negative_Correlation	5054	5340
17047299	Association	MESH:D019636	7040
17047299	Bind	5327	5340
17047299	Negative_Correlation	5054	5327
17047299	Positive_Correlation	MESH:D000544	7040
17047299	Association	MESH:D019636	5054
17047299	Positive_Correlation	MESH:D000544	5054

